BIBLIOGRAFIA
1.Wheller AP,Bernard GR. Treating patients with sepsis. England Journal of Medicine 1999;340:207-214
2.Cesano G, Livigni S, Vallero A, Olivieri C, Borca M, Quarello F, Tetta C, Formica M.
Trattamento dello shock settico con l’impiego della CPFA (plasmafiltrazione e adsorbimento associate): impatto sull’emodinamica valutata con sistema PiCCO®
Giornale Italiano di Nefrologia 2003;Anno 20 n. 3:1-6
3.Cavaillon JM, Adib-Conquy M, Cloez-Tayarani I, Fitting C. Immunodepression in sepsis and SIRS assessed by ex vivo cytokine productionin not a generalized phenomenon: a review.
Endotoxin Res 2001; 7 (2): 85-93.
4. Ronco C, Bonello M, Bordoni V, Ricci Z, D'Intini V, Bellomo R, LevinNW.
Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis.
Blood Purif. 2004;22(1):164-74.
5. Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process.
Chest. 1997 Jul;112(1):235-43.
6.Marcel Levi, Evert de Jonge, Tom van der Poll. Pathogenesis and treatment of disseminated intravascular coagulation.
Advences in Sepsis 2002; vol2 No 3:79-85
7.Levi M,ten Cate H, Bauer EKA, Buller HR,ten Cate JW,Rosemberg RD. Dose- dependent endotoxin-induced cytokine release and coagulation activation in chimpanzees.
Thromb Haemostas 1991;65:793
8.Pixley RA,DeLa Cadena R, Page JD et al. The contact system contributes to hypotension but not to disseminated intravascular coagulation in lethal bacteriemia.
J Clinical invest 1993;91:61-68
9.Vervloet M.G,Thijs L.G,Hack C.E. Alterazioni della coagulazione e della fibrinolisi in pazienti critici con sepsi e shock settico.
Seminar in trrombosis and hemostasis 1998;vol24,No1:33-44
10.Fourrier F,Chopin C,Goudemand J. Septic shock,multiple organ failure and disseminated intravascular coagulation. Compared patterns of antithrombin III, proteinC and protein S deficiences. Chest 1992;101:816-823
11.DeLa Cadena RA et al. Activation of the contact and fibrinolytic system after
intravenous administration of endotoxin to normal human volonteers:correlation with cytochine profile.
Immunopharmacology 1996;33:231-237
12.Hugo ten Cate et al. Microvascular coagulopathy and disseminated intravascular coagulation.
Critical Care Med 2001;vol 29,No7:95-98
13.JC, Marshall. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome.
Crit Care Med 2001;29(7 Suppl)S99-S106.
14.Housinger TA, Brinkerhoff C, Warden GD. The Relationship Between Platelets Count, Sepsis, and Survival in Pediatric Burn Patients.
Arch Surg 1993;128(1):65-67.
15.Mavrommatis AC, Theodoridis T, Orfanidou A, Roussos C, Christopoulou-
Kokkinou V, Zakynthinos S.Coagulation system and platelets are fully activated in uncomplicated sepsis.
Crit Care Med 2000 Feb;28(2):451-7.
16.Yaguchi A, Lobo FLM, Vincent JL, et all. Platelet function in sepsis.
17.Levi M. Platelets in sepsis. Hematology 2001;10(1):129-131.
18.Gawatz M, Fateh-Moghadam F, Pilz G, Gurland HJ, Werdan K. Severity of
multiple organ failure (MOF) but not of sepsis correlate with irreversible platelet degranulation.
Infection1995;23(1):16-23.
19.Boraso S. Patologia emocoagulativa e suo trattamento in corso di sepsi.
Padova Digital University Archive, ID 974, 22 ottobre 2008.
20. Bernardo A, Ball C, Nolasco L, Moake JF, DondJ-f
Effects of inflammatory cytokines on the release and cleavage of the endothelial cell–derived ultralarge von Willebrand factor multimers under flow.
Blood 2004 ;104 (1):100-108
21.Tomoko Ono, Jun Mimuro, Seiji Madoiwa, Kenji Soejima, Yuji Kashiwakura, Akira Ishiwata, Katsuhiro Takano, Tsukasa Ohmori and Yoichi Sakata
Severe secondary deficiency of von Willebrand factor–cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure
Blood 2006 ;107: 528-534
22. Martin K, Borgel D, Lerolle N, Feys HB, Trinquart L, Vanhoorelbeke K, Deckmyn
H, Legendre P, Diehl JL, Baruch D. Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure.
Crit Care Med 2007; Vol. 35, No. 10 :2375-2382
23. Bianchi V, Robles R, Alberio L, et al. Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura.
Blood 2002; 100:710 –713
24. Bellomo R., Baldwin I., Cole L., Ronco C. Preliminary experience with high volume hemofiltration in human septic shock.
Kidney Int 1988; 53: 182-5.
25. Reeves JH, Butt W\V, Shann F, et al. Continuous plasmafiltration in sepsis syndrome.
Crit Care Med 1999; 27: 2096-104.
26.Formica M, Ingaggiato P, Bainotti S, Wratten ML. Coupled plasma filtration adsorption.Contrib Nephrol. Basel, Karger,2001;156:405-410
27.Formica M, Olivieri C, Livigni S et al. Hemodynamic response to coupled plasma filtration-adsorption in human septic shock.
Intensive Care Med 2003; 29: 703–708.
28.Ronco C, Brendolan A, Lonnemann G, Bellomo R, et al. A pilot study of coupled plasma filtration with adsorption in septic shock.
Crit Care Med 2002;30:1250-1255.
29. Ronco C, Brendolan A et al.Coupled Plasma
Filtration Adsorption: Rationale, Technical Development and Early Clinical Experience.
Blood Purif 2003;21:409–416.
30. Flynn A, Mani PC, Mather PJ. Sepsis-induced cardiomyopathy:a review of pathophysiologic mechanisms.
Heart Fail Rev DOI 10.1007/s10741-010-9176-4.
31. Dhainaut J-F, Marin N, Mignon A, Vinsonneau C. Hepatic response to sepsis:
Interaction between coagulation and inflammatory process.
Crit Care Med, 2001; 29(Suppl): S42–S47.
32.MartinTR. Lung Cytokines and ARDS.
CHEST July 1999 vol. 116 no. suppl 1 2S-8S.
33.Cairns CB et al. Evidence for early supply independent mitochrondrial dysfunction in patients developing multiple organ failure after trauma.J Trauma 1997; 42:532–6.
34.Dellinger et al .Surviving Sepsis Campaign: International guidelines for management
of severe sepsis and septic shock: 2008 Intensive Care Med (2008) 34:17–6035.
35. Claus R.A, Bockmeyer C.L,*Sossdorf M , Lo¨ Sche and Hilberg T.Physical stress as a model to study variations in ADAMTS-13 activity, von Willebrand factor level and platelet activation.2006 International Society on Thrombosis and Haemostasis
36.De Backer D, Creteur J, Silva E, Vincent JL. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?
Crit Care Med 31(2003):1659–1667.
37. Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?
Chest 103 (1993):1826–1831.
38. Martin C, Viviand X, Leone M, Thirion X. Effect of norepinephrine on the outcome of septic shock.
Crit Care Med 28 (2000):2758–2765.
39.Sprung CL, Annane D, Briegel J, et al. Corticosteroid therapy of septic shock (CORTICUS).
Abstr. Am Rev Respir Crit.
40.The ACCP/SCCM Consensus conference committee: Bone RC, Balk RA, Cerra FB et al. Definition for sepsis and organ failure and guidelines for the use of innovative terapie in sepsis.
Chest 1992; 101:1644-55.
41. Keene AR, Cullen DJ. Therapeutic intervention scoring system: update.
Critical Care Med 1983;11:1-3.
42.Cruz, Dinna N.et al.Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock: The EUPHAS Randomized Controlled Trial.
JAMA 2009;301(23):2445-2452.
43.Mariano et al. Regional citrate anticoagulation in critically ill patients treated with coupled plasma filtration and adsorption.
Blood Purif 2004;22:313-319
44.Wratten M.L. Therapeutic approaches to reduce systemic inflammation in septic- associated neurologic complications.
European Journal of Anaesthesiology 2008; 25 (Suppl 42): 1–7
45.Biron C, Bengler C, Gris JC, Schved JF. Acquired Isolated Factor VII Deficiency during Sepsis.
Patoph oh Haem and Thromb, vol. 27, No. 2, 1997
46. Noe DA, Murphy PA, Bell WR, Siegel JN.Acute-phase behavior of factor VIII procoagulant and other acute-phase reactants in rabbits.
Am J Physiol Regul Integr Comp Physiol, 257: R49-R56,1989.
47.Donadelli R, Orje J.N, Capoferri C, Remuzzi G and Ruggeri M. Size regulation of von Willebrand factor–mediated platelet thrombi by ADAMTS-13 in flowing blood.
Blood2006 107: 1943-1950
48.Pralog G,Calandra T, Glauser MP et al. Plasminogen activator inhibitor 1:a new prognostic marker in septic shock.
Thromb Haemostas 1989 61: 459-462
